首页> 外文期刊>Biological chemistry >Analysis of an engineered plasma kallikrein inhibitor and its effect on contact activation.
【24h】

Analysis of an engineered plasma kallikrein inhibitor and its effect on contact activation.

机译:工程血浆激肽释放酶抑制剂的分析及其对接触激活的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

Engineering of protein-protein interactions is used to enhance the affinity or specificity of proteins, such as antibodies or protease inhibitors, for their targets. However, fully diversifying all residues in a protein-protein interface is often unfeasible. Therefore, we limited our phage library for the serine protease inhibitor ecotin by restricting it to only tetranomial diversity and then targeted all 20 amino acid residues involved in protein recognition. This resulted in a high-affinity and highly specific plasma kallikrein inhibitor, ecotin-Pkal. To validate this approach we dissected the energetic contributions of each wild type (wt) or mutated surface loop to the binding of either plasma kallikrein (PKal) or membrane-type serine protease 1. The analysis demonstrated that a mutation in one loop has opposing effects depending on the sequence of surrounding loops. This finding stresses the cooperative nature of loop-loop interactions and justifies targeting multiple loops with a limited diversity. In contrast to ecotin wt, the specific loop combination of ecotin-Pkal discriminates the subtle structural differences between the active enzymes, PKal and Factor XIIa, and their respective zymogen forms. We used ecotin-Pkal to specifically inhibit contact activation of human plasma at the level mediated by plasma kallikrein.
机译:蛋白质-蛋白质相互作用的工程设计用于增强蛋白质(例如抗体或蛋白酶抑制剂)对其靶标的亲和力或特异性。然而,使蛋白质-蛋白质界面中的所有残基完全多样化通常是不可行的。因此,我们将丝氨酸蛋白酶抑制剂Ecotin的噬菌体文库限制为只有四项式多样性,然后针对所有20个氨基酸残基进行蛋白质识别。这产生了高亲和力和高特异性血浆激肽释放酶抑制剂,Ecotin-Pkal。为了验证这种方法,我们解剖了每种野生型(wt)或突变的表面环对血浆激肽释放酶(PKal)或膜型丝氨酸蛋白酶1结合的能量贡献。分析表明,一个环中的突变具有相反的作用取决于周围循环的顺序。这一发现强调了回路与回路相互作用的合作性质,并证明了针对多样性有限的多个回路的合理性。与Ecotin wt相比,Ecotin-Pkal的特定环组合可区分活性酶PKal和因子XIIa及其各自的酶原形式之间的细微结构差异。我们使用ecotin-Pkal特异性抑制血浆激肽释放酶介导的人类血浆接触活化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号